drugset / Trial / NCT03601923
Niraparib in Patients With Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying an investigational therapy as a possible treatment for pancreatic cancer. The drugs involved in this study are: -Niraparib
Timeline
- Start
- 2018-08-22
- Primary completion
- 2025-12-31
- Completion
- 2026-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niraparib | Small molecule | 200 mg | Oral |
| Subject | Niraparib | Small molecule | 300 mg | Oral |